Treatment of cardiac tissue following myocardial infarction utilizing high intensity focused ultrasound

• US 20050165298A1
• Filed: 03/18/2005
• Published: 07/28/2005
• Est. Priority Date: 09/04/2003
• Status: Abandoned Application

• Current Assignee: Sonorhythm, LLC
• Original Assignee: Crum, Kaminski & Larson, LLC
• Inventors: Larson, Eugene A., Kaminski, Perry W.
• Application Number:
  US11/084,568
• Publication Number:
  US 20050165298A1
• Time in Patent Office: Days
• US Class Current: 600/410
• CPC Class Codes: A61B 2017/00243 cardiac
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61N 7/02 Localised ultrasound hyperthermia hyperthermia in general A61F7/00
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

A noninvasive or minimally invasive treatment of infarct areas of the heart with High Intensity Focused Ultrasound (HIFU) emitted without respect to the timing or phase of the cardiac cycle, intended to remodel cardiac tissue by inducing angiogenesis and/or the formation of myocytes to improve cardiac function.

Claims

1. A method for reducing the debilitating effects of myocardial infarctions in a heart, said method comprising:

targeting a region of interest of the heart by diagnostic imaging;

emitting without timing to the heart cycle or position, and in a continual manner, therapeutic ultrasound energy from an ultrasound radiating surface placed on the skin or in the esophagus;

focusing the emitted therapeutic ultrasound energy on the region of interest throughout the heart cycle; and

,

producing sub-lethal or partially lethal tissue or cellular damage in the region of interest thereby inducing at least one of regeneration of myocardial cells and angiogenesis in the region of interest.

2. The method of claim 1 wherein said targeting is carried out with diagnostic ultrasound.

3. The method of claim 1 wherein said targeting is carried out with Magnetic Resonance Imaging.

4. The method of claim 1 wherein the region of interest comprises a ventricular wall of the heart.

5. The method of claim 1 in which the ultrasound radiating surface is located in the esophagus.

6. The method of claim 1 in which the ultrasound radiating surface is located on the skin and the energy is delivered transthoracically.

7. The method of claim 6 wherein the energy is delivered intercostally or subcostally.

8. The method of claim 2 in which pulse echo signals from the diagnostic array is used to deliver the emitted therapeutic ultrasound energy in phase with the heart motion thereby delivering ultrasound energy in a continual manner without respect to the timing or phase of the heart cycle, interrupted only briefly to acquire imaging frames.

9. The method of claim 1 in which the emitted ultrasound energy produces sub-lethal tissue damage in a region of the infarction or other regions of interest.

10. The method of claim 1 wherein said therapeutic ultrasound comprises high intensity focused ultrasound (HIFU) emitted in a substantially continuous manner without respect to timing or phase of the cardiac cycle.

11. The method of claim 2 wherein said targeting further comprises:

placing an ultrasonic device at the region of interest, said device generating a signal which identifies the infarction via the diagnostic imaging and provides a focus location for the therapeutic ultrasound, and wherein the device signal is also received by the imaging transducer and electronics which provide phase aberration correction feedback data to the therapeutic ultrasound system to accurately generate the therapeutic ultrasound focus and to overcome diffraction limits by expanding the effective aperture of the therapeutic ultrasound transducer.

12. A method for providing for non-invasive or minimally invasive treatment of myocardial infarction utilizing therapeutic ultrasound, emitted without respect to the timing or phase of the cardiac cycle, said method comprising:

inducing at least one of injury to cardiac cells, phase transitions, changes in the shape of cell proteins, and structural protein remodeling in a defined volume, whereby tissues regenerate over time in a manner which reduces the volume of the infarction and increases cardiac output.

13. The method of claim 12 wherein said inducing is effected with High Intensity Focused Ultrasound.